Citadel Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224M | Sell |
1,030,200
-402,600
| -28% | -$89.3M | 0.04% | 407 |
|
|
2025
Q4 | $327M | Sell |
1,432,800
-456,400
| -24% | -$104M | 0.05% | 308 |
|
|
2025
Q3 | $437M | Buy |
1,889,200
+648,300
| +52% | +$132M | 0.07% | 224 |
|
|
2025
Q2 | $230M | Sell |
1,240,900
-1,107,000
| -47% | -$206M | 0.04% | 363 |
|
|
2025
Q1 | $492M | Buy |
2,347,900
+937,100
| +66% | +$182M | 0.09% | 132 |
|
|
2024
Q4 | $251M | Sell |
1,410,800
-457,300
| -24% | -$84.1M | 0.04% | 318 |
|
|
2024
Q3 | $369M | Buy |
1,868,100
+1,088,300
| +140% | +$203M | 0.07% | 197 |
|
|
2024
Q2 | $134M | Sell |
779,800
-753,000
| -49% | -$125M | 0.03% | 522 |
|
|
2024
Q1 | $279M | Buy |
1,532,800
+397,800
| +35% | +$68.6M | 0.05% | 259 |
|
|
2023
Q4 | $176M | Sell |
1,135,000
-341,800
| -23% | -$49.8M | 0.04% | 401 |
|
|
2023
Q3 | $220M | Sell |
1,476,800
-624,100
| -30% | -$91.6M | 0.05% | 286 |
|
|
2023
Q2 | $283M | Sell |
2,100,900
-123,700
| -6% | -$18.1M | 0.06% | 191 |
|
|
2023
Q1 | $355M | Sell |
2,224,600
-265,700
| -11% | -$40.6M | 0.08% | 159 |
|
|
2022
Q4 | $402M | Buy |
2,490,300
+313,000
| +14% | +$48M | 0.09% | 147 |
|
|
2022
Q3 | $292M | Sell |
2,177,300
-335,100
| -13% | -$48.1M | 0.07% | 190 |
|
|
2022
Q2 | $385M | Sell |
2,512,400
-469,100
| -16% | -$71.7M | 0.1% | 124 |
|
|
2022
Q1 | $483M | Buy |
2,981,500
+1,316,514
| +79% | +$191M | 0.1% | 110 |
|
|
2021
Q4 | $225M | Sell |
1,664,986
-617,000
| -27% | -$72.9M | 0.05% | 301 |
|
|
2021
Q3 | $246M | Buy |
2,281,986
+329,500
| +17% | +$37.7M | 0.05% | 277 |
|
|
2021
Q2 | $220M | Buy |
1,952,486
+210,100
| +12% | +$23.7M | 0.05% | 288 |
|
|
2021
Q1 | $189M | Buy |
1,742,386
+206,138
| +13% | +$22M | 0.05% | 312 |
|
|
2020
Q4 | $165M | Sell |
1,536,248
-252,752
| -14% | -$24.3M | 0.04% | 330 |
|
|
2020
Q3 | $157M | Sell |
1,789,000
-157,800
| -8% | -$14.9M | 0.04% | 273 |
|
|
2020
Q2 | $191M | Buy |
1,946,800
+72,200
| +4% | +$6.36M | 0.07% | 194 |
|
|
2020
Q1 | $143M | Sell |
1,874,600
-2,249,800
| -55% | -$192M | 0.06% | 219 |
|
|
2019
Q4 | $365M | Buy |
4,124,400
+630,600
| +18% | +$52.4M | 0.16% | 71 |
|
|
2019
Q3 | $265M | Buy |
3,493,800
+472,500
| +16% | +$32.4M | 0.12% | 105 |
|
|
2019
Q2 | $220M | Buy |
3,021,300
+1,143,900
| +61% | +$89.9M | 0.1% | 141 |
|
|
2019
Q1 | $151M | Buy |
1,877,400
+571,500
| +44% | +$46.8M | 0.08% | 219 |
|
|
2018
Q4 | $120M | Sell |
1,305,900
-10,700
| -0.8% | -$941K | 0.07% | 267 |
|
|
2018
Q3 | $125M | Buy |
1,316,600
+255,800
| +24% | +$24.3M | 0.06% | 333 |
|
|
2018
Q2 | $98.3M | Buy |
1,060,800
+184,100
| +21% | +$18M | 0.05% | 376 |
|
|
2018
Q1 | $83M | Buy |
876,700
+155,200
| +22% | +$17M | 0.05% | 390 |
|
|
2017
Q4 | $69.8M | Buy |
721,500
+100,300
| +16% | +$9.45M | 0.04% | 466 |
|
|
2017
Q3 | $55.2M | Buy |
621,200
+126,900
| +26% | +$9.66M | 0.04% | 497 |
|
|
2017
Q2 | $35.8M | Buy |
494,300
+49,800
| +11% | +$3.35M | 0.03% | 661 |
|
|
2017
Q1 | $29M | Sell |
444,500
-105,000
| -19% | -$6.6M | 0.03% | 739 |
|
|
2016
Q4 | $34.4M | Buy |
549,500
+75,900
| +16% | +$4.63M | 0.03% | 553 |
|
|
2016
Q3 | $29.9M | Buy |
473,600
+106,400
| +29% | +$6.89M | 0.03% | 640 |
|
|
2016
Q2 | $22.7M | Buy |
367,200
+33,400
| +10% | +$2.04M | 0.03% | 693 |
|
|
2016
Q1 | $19.1M | Buy |
333,800
+74,200
| +29% | +$4.14M | 0.02% | 774 |
|
|
2015
Q4 | $15.4M | Sell |
259,600
-48,000
| -16% | -$2.76M | 0.02% | 997 |
|
|
2015
Q3 | $16.7M | Buy |
307,600
+66,000
| +27% | +$4.3M | 0.02% | 1005 |
|
|
2015
Q2 | $16.2M | Buy |
241,600
+26,600
| +12% | +$1.74M | 0.01% | 1144 |
|
|
2015
Q1 | $12.6M | Sell |
215,000
-48,200
| -18% | -$2.91M | 0.01% | 1270 |
|
|
2014
Q4 | $17.2M | Buy |
263,200
+147,000
| +127% | +$9.27M | 0.02% | 1046 |
|
|
2014
Q3 | $6.71M | Sell |
116,200
-54,500
| -32% | -$3.03M | 0.01% | 1716 |
|
|
2014
Q2 | $9.63M | Buy |
170,700
+72,900
| +75% | +$3.82M | 0.01% | 1293 |
|
|
2014
Q1 | $5.03M | Sell |
97,800
-73,300
| -43% | -$3.7M | 0.01% | 1782 |
|
|
2013
Q4 | $9.04M | Buy |
171,100
+28,400
| +20% | +$1.4M | 0.01% | 1268 |
|
|
2013
Q3 | $6.38M | Buy |
142,700
+46,800
| +49% | +$2.07M | 0.01% | 1398 |
|
|
2013
Q2 | $3.96M | Buy |
+95,900
| New | +$4.19M | 0.01% | 1784 |
|
Other funds holding ABBV
VCM
VPM
Citadel Advisors's ABBV Position: Q1 2026 in Review
Citadel Advisors reduced its AbbVie (ABBV) stake by 33% in Q1 2026, selling an estimated $53.9M and leaving 490,285 shares worth $107M. The position accounts for 0.02% of the portfolio, ranked #768.
Citadel Advisors first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $719M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Citadel Advisors held 490,285 shares of AbbVie worth $107M as of Q1 2026.
- Citadel Advisors sold 243,066 AbbVie shares in Q1 2026, an estimated $53.9M.
- AbbVie made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #768 holding.
- Citadel Advisors first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Citadel Advisors's AbbVie position peaked at $719M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.